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Table S1-1: Dominant hydrogen bonds for sub-ensembles of native oxytocin. 
 
Rg bounds Acceptor Donor Percent of sub-ensemble 
4.0-4.62 Å 
(compact) 
Tyr2-O Asn5-NH 73.9% 
Tyr2-O Cys6-NH 68.2% 
Cys6-O Gly9-NH 49.9% 
Gln4-OE1 Gln4-NH 15.1% 
Pro7-O C terminus-NH1 14.3% 
5.0-5.7 Å 
(extended) 
Tyr2-O Asn5-NH 81.6% 
Tyr2-O Cys6-NH 78.6% 
 
Table S1-2: Dominant hydrogen bonds for sub-ensembles of Q4T mutant of oxytocin. 
 
Rg bounds Acceptor Donor Percent of sub-ensemble 
3.9-4.3 Å 
(compact) 
Tyr2-O Asn5-NH 85.9% 
Tyr2-O Cys6-NH 84.2% 
Cys6-O Gly9-NH 71.2% 
Pro7-O C terminus-NH1 29.3% 
Cys1-O C terminus-NH2 12.7% 
5.0-5.6 Å 
(extended) 
Tyr2-O Asn5-NH 79.5% 




Table S1-3: Dominant hydrogen bonds for sub-ensembles of Q4T,P7G mutant of oxytocin. 
 
Rg bounds Acceptor Donor Percent of sub-ensemble 
5.13-5.5 Å 
(extended) 
Tyr2-O Asn5-NH 87.6% 
Tyr2-O Cys6-NH 72.7% 
Cys6-O Gly9-NH 71.2% 
Asn5-OD1 Tyr2-NH 10.2% 
 
Table S1-4: Dominant hydrogen bonds for sub-ensembles of native vasopressin. 
 
Rg bounds Acceptor Donor Percent of sub-ensemble 
4.1-4.43 Å 
(compact) 
Tyr2-O Asn5-NH 92.2% 
Tyr2-O Cys6-NH 59.6% 
Pro7-O C terminus-NH1 36.3% 
Cys6-O Gly9-NH 31.1% 
Cys1-O C terminus-NH2 12.1% 
Pro7-O Gly9-NH 11.0% 
4.95-5.6 Å 
(extended) 
Tyr2-O Asn5-NH 90.7% 
Tyr2-O Cys6-NH 63.5% 
5.7-6.0 Å 
(extended) 
Tyr2-O Asn5-NH 88.7% 
Tyr2-O Cys6-NH 41.5% 
Phe3-O Cys6-NH 17.4% 
 
Table S1-5: Dominant hydrogen bonds for sub-ensembles of Y2H mutant of vasopressin. 
 
Rg bounds Acceptor Donor Percent of sub-ensemble 
4.0-4.48 Å 
(compact) 
His2-O Asn5-NH 87.5% 
His2-O Cys6-NH 76.7% 
His2-ND1 Gln4-NH 87.6% 
Pro7-O C terminus-NH1 33.4% 
Cys6-O Gly9-NH 30.7% 
Cys1-O C terminus-NH1 22.2% 
4.85-5.67 Å 
(extended) 
His2-O Asn5-NH 80.6% 
His2-O Cys6-NH 79.7% 




Table S1-6: Dominant hydrogen bonds for sub-ensembles of Y2H+ mutant of vasopressin. 
 
Rg bounds Acceptor Donor Percent of sub-ensemble 
4.2-4.48 Å 
(compact) 
His2-O Asn5-NH 74.6% 
His2-O Cys6-NH 15.6% 
His2-O C terminus-NH2 62.6% 
Cys6-O Gly9-NH 58.3% 
Gly9-O Cys6-NH 54.8% 
Asn5-OD1 His2-HD1 12.8% 
5.45-6.25 Å 
(extended) 
His2-O Asn5-NH 62.4% 
His2-O Cys6-NH 18.9% 
Asn5-OD1 His2-HD1 35.7% 
 
Table S1-7: Dominant hydrogen bonds for sub-ensembles of P7L mutant of vasopressin. 
 
Rg bounds Acceptor Donor Percent of sub-ensemble 
4.5-4.9 Å 
(compact) 
Tyr2-O Asn5-NH 31.9% 
Tyr2-O Cys6-NH 16.0% 
Asn5-OD1 Leu7-NH 22.8% 
Gln4-O Arg8-NH 22.2% 
Phe3-O Cys6-NH 18.9% 
Asn5-O Arg8-NH 17.5% 
Phe3-O Leu7-NH 17.0% 
Tyr2-O Cys6-NH 16.0% 
Phe3-O Asn5-NH 13.44% 
Gln4-O Leu7-NH 12.4% 
5.0-5.5 Å 
(extended) 
Tyr2-O Asn5-NH 41.4% 
Gln4-O Leu7-NH 26.3% 
Phe3-O Cys6-NH 22.1% 
Asn5-O Arg8-NH 18.0% 
5.7-6.1 Å 
(extended) 
Tyr2-O Asn5-NH 44.2% 
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Table S2-1: Percentages of sub-ensembles of native oxytocin with specific DSSP1 secondary 
structure. Blank entries imply 0.0%. 
 
Rg bounds Residue β-bridge 310 helix Turn  
4.0-4.62 Å 
(compact) 
1    
2    
3  2.6% 83.6% 
4  2.6% 85.1% 
5  2.6% 84.1% 
6 1.6%   
7   67.6% 
8   67.5% 
9 1.6%   
5.0-5.7 Å 
(extended) 
1    
2    
3  3.6% 92.0% 
4  3.6% 92.2% 
5  3.6% 91.2% 
6    
7   1.0% 
8    
9    
 
Table S2-2: Percentages of sub-ensembles of Q4T mutant of oxytocin with specific DSSP1 
secondary structure. Blank entries imply 0.0%. 
 
Rg bounds Residue 310 helix Turn 
3.9-4.3 Å 
(compact) 
1   
2   
3 1.2% 98.3% 
4 1.2% 98.4% 
5 1.2% 98.4% 
6  1.9% 
7  90.4% 
8  90.5% 
9   
5.0-5.6 Å 
(extended) 
1   
2   
3 1.6% 95.4% 
4 1.6% 95.8% 
5 1.6% 95.1% 
6   
7   
8   
9   
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Table S2-3: Percentages of sub-ensembles of Q4T,P7G mutant of oxytocin with specific DSSP1 
secondary structure. Blank entries imply 0.0%. 
 
Rg bounds Residue 310 helix α-helix Turn 
5.13-5.5 Å 
(compact) 
1    
2    
3 4.3% 12.8% 79.7% 
4 4.3% 12.8% 80.0% 
5 4.3% 12.8% 78.3% 
6  12.8% 13.0% 
7   11.8% 
8   1.0% 
9    
 
Table S2-4: Percentages of sub-ensembles of native vasopressin with specific DSSP1 secondary 
structure. Blank entries imply 0.0%. 
 
Rg bounds Residue 310 helix Turn 
4.1-4.43 Å 
(compact) 
1   
2   
3 8.7% 91.0% 
4 8.7% 91.0% 
5 8.7% 87.0% 
6  2.8% 
7  63.6% 
8  62.9% 
9   
4.95-5.6 Å 
(extended) 
1   
2   
3 8.3% 91.6% 
4 8.3% 91.7% 
5 8.3% 88.2% 
6  1.0% 
7  1.0% 
8   
9   
5.7-6.0 Å 
(extended) 
1   
2   
3 23.1% 76.9% 
4 23.1% 76.9% 
5 23.1% 72.5% 
6   
7   
8   
9   
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Table S2-5: Percentages of sub-ensembles of Y2H mutant of vasopressin with specific DSSP1 
secondary structure. Blank entries imply 0.0%. 
 
Rg bounds Residue 310 helix Turn 
4.0-4.48 Å 
(compact) 
1   
2   
3 1.0% 98.9% 
4 1.0% 98.8% 
5 1.0% 98.0% 
6  3.0% 
7  68.4% 
8  68.5% 
9   
4.85-5.67 Å 
(extended) 
1   
2   
3 1.6% 97.7% 
4 1.6% 97.6% 
5 1.6% 96.4% 
6  1.6% 
7  1.6% 
8   
9   
 
Table S2-6: Percentages of sub-ensembles of Y2H+ mutant of vasopressin with specific DSSP1 
secondary structure. Blank entries imply 0.0%. 





310 helix Turn 
4.2-4.48 Å 
(compact) 
1     
2     
3 7.2%  1.1% 86.7% 
4   1.1% 97.4% 
5   1.1% 55.0% 
6 7.2% 58.0%   
7    77.3% 
8    77.3% 
9  58.0%   
5.45-6.25 Å 
(extended) 
1     
2  2.2% 2.6%  
3 1.0%  3.4% 83.8% 
4   3.4% 90.8% 
5  2.2% 1.0% 58.5% 
6 1.0%    
7     
8     
9     
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Table S2-7: Percentages of sub-ensembles of P7L mutant of vasopressin with specific DSSP1 
secondary structure. Blank entries imply 0.0%. 
 





310 helix α-helix Turn 
4.5-4.9 Å 
(compact) 
1      
2  7.9% 3.5%   
3 1.9%  3.5% 1.0% 47.8% 
4   5.3% 14.9% 60.3% 
5  7.6% 4.0% 19.4% 42.5% 
6 1.9%  4.3% 19.4% 34.6% 
7   3.2% 18.7% 34.7% 
8   1.1% 5.7% 22.0% 
9      
5.0-5.5 Å 
(extended) 
1      
2  1.0% 6.0%   
3 1.0%  6.1%  47.3% 
4   12.9% 1.6% 76.7% 
5  1.0% 16.2% 1.8% 66.7% 
6 1.0%  17.3% 1.8% 42.3% 
7   12.0% 1.7% 29.0% 
8   1.6%  10.4% 
9      
5.7-6.0 Å 
(extended) 
1      
2  3.1% 1.0%   
3   1.3%  57.4% 
4   2.6%  81.5% 
5  3.1% 2.2%  62.3% 
6   2.1%  19.8% 
7   1.0%  7.7% 
8      














Table S3-1: The experimental and simulated chemicals shifts for native Oxytocin. Experimental 
values taken from Ohno et al.2  
 
 Cα  Cβ  Hα  HN 
Residue Exp Sim  Exp Sim  Exp Sim  Exp Sim 
1 56.10 55.32  43.90 42.34  3.98 4.69    
2 58.10 57.59  39.10 39.62  4.85 4.67  8.23 8.58 
3 62.50 63.00  39.00 37.77  4.16 3.80  7.88 7.51 
4 58.00 56.71  28.70 28.98  4.13 4.16  8.21 7.44 
5 53.40 53.83  38.60 39.75  4.75 4.74  8.33 7.91 
6 54.50 52.88  41.50 42.15  4.85 5.03  8.23 7.91 
7 63.50 63.08  32.10 32.24  4.46 4.44    
8 55.60 55.24  42.20 42.56  4.32 4.27  8.49 8.16 
9 45.10 45.73     3.95 3.89  8.41 8.07 
 
 
Table S3-2: The experimental and simulated chemicals shifts for native Oxytocin. Experimental 
values taken from Sikorska et al.3 
 
 Cα  Cβ  Hα  HN 
Residue Exp Sim  Exp Sim  Exp Sim  Exp Sim 
1 52.55 55.09  40.04 42.56  4.20 4.71    
2 55.47 57.50  36.47 39.54  4.56 4.72  8.76 8.64 
3 55.92 59.94  36.54 38.45  4.37 4.37  8.02 8.34 
4 55.15 56.58  25.84 28.70  4.02 3.98  8.18 6.72 
5 50.41 53.55  35.90 40.05  4.69 4.79  8.19 7.84 
6 51.31 53.25  38.62 42.40  4.81 4.99  8.00 7.79 
7 60.73 63.08  29.73 32.18  4.35 4.43    
8 53.80 56.24  27.98 30.84  4.20 4.22  8.49 8.27 
















Figure S1. Difference between the simulated Rg distributions of native oxytocin for two 
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